Argentina vs Bahamas: Access to anti-retroviral drugs, male
Argentina
74.0%
in 2024
Bahamas
74.0%
in 2024
Argentina rank
58th
Bahamas rank
58th
Access to anti-retroviral drugs, male over time
- Argentina
- Bahamas
How they compare
Argentina currently reports 74.0% against 74.0% in Bahamas, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Argentina ahead.
Argentina ranks 58th and Bahamas ranks 58th of 141 countries.
Across the 3 decades both report, Argentina averaged higher in 2 and Bahamas in 1.
Head to head by decade
| Decade | Argentina | Bahamas | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 16.9% | 12.6% | Argentina |
| 2010s | 56.3% | 47.5% | 8.8% | Argentina |
| 2020s | 71.6% | 71.8% | 0.2% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Argentina or Bahamas?
- Argentina, at 74.0% against 74.0% in Bahamas as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Argentina and Bahamas?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Bahamas?
- 25 years are reported by both, from 2000 to 2024.
- How do Argentina and Bahamas rank globally for access to anti-retroviral drugs, male?
- Argentina ranks 58th and Bahamas ranks 58th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.